SCHEMBL19628166

SCHEMBL19628166

c1ccc2cc(-c3ccc4ccc5c(-c6cc7cccc8c9c%10ccccc%10sc9c9cccc6c9c78)ccc6ccc3c4c65)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 9/20 0.39
S1PR4 O95977 7/20 0.39
ALOX5 P09917 1/20 0.37
CYP1A2 P05177 3/20 0.36
ERBB2 P04626 1/20 0.36
FYN P06241 1/20 0.36
MAOA P21397 1/20 0.36
ACHE P22303 1/20 0.36
AHR P35869 1/20 0.36
GSTP1 P09211 1/20 0.34
ALDH1A1 P00352 3/20 0.33
HPGD P15428 3/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
HCRTR1 O43613 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
GPR84 Q9NQS5 1/20 0.33
HSD17B10 Q99714 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19628153 0.91 ALOX5 (0.41) S1PR5S1PR4ALOX5CYP1A2ERBB2
SCHEMBL19628151 0.91 CYP1A2 (0.39) S1PR5S1PR4ALOX5CYP1A2ERBB2
SCHEMBL19628168 0.90 F9 (0.39) S1PR5S1PR4ALOX5CYP1A2ERBB2
SCHEMBL19628173 0.90 CYP1A2 (0.45) ALOX5CYP1A2ERBB2FYNMAOA
SCHEMBL19628179 0.89 ALOX5 (0.38) S1PR5S1PR4ALOX5CYP1A2ERBB2
SCHEMBL19628177 0.88 CYP1A2 (0.40) ALOX5CYP1A2ERBB2FYNMAOA
SCHEMBL19628169 0.87 CYP1A2 (0.35) ALOX5CYP1A2ERBB2FYNMAOA
SCHEMBL19628134 0.86 ALOX5 (0.36) S1PR5S1PR4ALOX5CYP1A2ERBB2
SCHEMBL19628161 0.86 GSTP1 (0.36) S1PR5S1PR4ALOX5CYP1A2ERBB2
SCHEMBL19628162 0.86 S1PR5 (0.36) S1PR5S1PR4ALOX5CYP1A2ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439144-B2 Organic compound for electronic device comprising fused-core structure, organic optoelectronic device comprising same, and display device UNIVERSITY-INDUSTRY COOPERATEON GROUP OF KYUNG HEE UNIVERSITY (KR) 2019-10-08 US disclosed
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) 2017-11-23 US disclosed
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439144-B2 Organic compound for electronic device comprising fused-core structure, organic optoelectronic device comprising same, and display device OR10J3, OCIAD2, OCIAD1 S1PR5 4820/4885S1PR4 4615/4885ALOX5 1129/4885
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 S1PR5 4820/4885S1PR4 4615/4885ALOX5 1129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.